You are here

P&T® Journal contents for November 2001

Features

The authors evaluate the results of clinical trials studying the efficacy and safety of the combined use of anticoagulant and anti-platelet agents in thromboembolic disorders.
Thomas L. Lenz, PharmD and Daniel E. Hilleman, PharmD
This recurring feature focuses on a new drug for B-cell CLL.
Marvin. M. Goldenberg, PhD
Continuing Education Credit
This article reviews drugs that fight HIV, and discusses their side effects, contraindications, and how they affect the virus’ life cycle.
Claudine El-Beyrouty, PharmD

Departments

Editorial
Karl A. Matuszewski, MS, PharmD, Associate Editor-in-Chief, gears up to tackle “Budgeting for the Future.”
Karl A. Matuszewski, MS, PharmD
Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Prescription Washington
Stephen Barlas
Sirolimus dosing errors, confusion among Zydis products, and avoiding symbol shorthand are discussed.
Matthew Grissinger, RPh
Drug Forecast
A new insulin inhaler provides a method of insulin delivery that is noninvasive, for patients with type 1 and type 2 diabetes.
Jennifer Matthews, PharmD Candidate and Vitalina Rozenfeld, PharmD, BCPS